CD163 and neoplasm: Increased levels of tumor associated M2 macrophages (M2 TAM) in the pre-operative biopsy tissues, such as CD68 or CD163 positive macrophages, have been associated with reduced responses to therapy and more frequent non-pCR results [28,29].